Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Boehringer Ingelheim
Medtronic
McKinsey
Mallinckrodt

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Aurobindo Pharma Ltd Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for AUROBINDO PHARMA LTD, and what generic and branded alternatives to AUROBINDO PHARMA LTD drugs are available?

AUROBINDO PHARMA LTD has two hundred and ninety-three approved drugs.

There are sixteen tentative approvals on AUROBINDO PHARMA LTD drugs.

Summary for Aurobindo Pharma Ltd

Drugs and US Patents for Aurobindo Pharma Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 202261-003 Nov 19, 2012 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd ESZOPICLONE eszopiclone TABLET;ORAL 208451-003 Sep 15, 2016 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 203962-002 Jun 11, 2018 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd AZITHROMYCIN azithromycin TABLET;ORAL 207398-001 Jul 5, 2018 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd FENOFIBRATE fenofibrate TABLET;ORAL 205118-001 May 5, 2016 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd ELETRIPTAN HYDROBROMIDE eletriptan hydrobromide TABLET;ORAL 210708-001 Jan 15, 2019 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd BUSPIRONE HYDROCHLORIDE buspirone hydrochloride TABLET;ORAL 078246-002 Feb 27, 2009 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for AUROBINDO PHARMA LTD drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Boehringer Ingelheim
Medtronic
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.